Comparison between Akums Drugs IPO and Emcure Pharmaceuticals IPO.
Akums Drugs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Emcure Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Akums Drugs IPO is up to ₹1,856.74 Cr whereas the issue size of the Emcure Pharmaceuticals IPO is up to ₹1,952.03 Cr. The final issue price of Akums Drugs IPO is ₹679.00 per share and of Emcure Pharmaceuticals IPO is ₹1,008.00 per share.
| Akums Drugs IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹646.00 per share | ₹960.00 per share |
| Issue Price (Upper) | ₹679.00 per share | ₹1,008.00 per share |
| Issue Price (Final) | ₹679.00 per share | ₹1,008.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹64.00 per share | ₹90.00 per share |
| Market Lot Size | 22 shares | 14 shares |
| Fresh Issue Size | 1,00,37,708 shares | 79,46,231 shares |
| Fresh Issue Size (Amount) | up to ₹680.99 Cr | up to ₹800.58 Cr |
| OFS Issue Size | 1,73,30,435 shares | 1,14,28,839 shares |
| OFS Issue Size (Amount) | up to ₹1,175.75 Cr | up to ₹1,151.45 Cr |
| Issue Size Total | 2,73,68,143 shares | 1,93,75,070 shares |
| Issue Size Total (Amount) | up to ₹1,856.74 Cr | up to ₹1,952.03 Cr |
Akums Drugs IPO opens on Jul 30, 2024, while Emcure Pharmaceuticals IPO opens on Jul 03, 2024. The closing date of Akums Drugs IPO and Emcure Pharmaceuticals IPO is Aug 01, 2024, and Jul 05, 2024, respectively.
| Akums Drugs IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Jul 29, 2024 | Jul 02, 2024 |
| Issue Open | Jul 30, 2024 | Jul 03, 2024 |
| Issue Close | Aug 01, 2024 | Jul 05, 2024 |
| Basis Of Allotment (Tentative) | Aug 02, 2024 | Jul 08, 2024 |
| Initiation of Refunds (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
| Credit of Share (Tentative) | Aug 05, 2024 | Jul 09, 2024 |
| Listing date (Tentative) | Aug 06, 2024 | Jul 10, 2024 |
| Anchor Lockin End date 1 | Sep 01, 2024 | Aug 07, 2024 |
| Anchor Lockin End date 2 | Oct 31, 2024 | Oct 06, 2024 |
Akums Drugs IPO P/E ratio is , as compared to Emcure Pharmaceuticals IPO P/E ratio of 34.55.
| Akums Drugs IPO | Emcure Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 82.48 | 83.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 75.29 | 78.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 34.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹19029.89 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 0.11% | 16.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 3.37% | 19.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.69 | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹29.17 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.57 | 16.87% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Akums Drugs IPO Retail Individual Investors (RII) are offered 27,12,424 shares while in Emcure Pharmaceuticals IPO retail investors are offered 27,12,424 shares. Qualified Institutional Buyers (QIB) are offered 81,37,276 shares in Akums Drugs IPO and 38,53,234 shares in Emcure Pharmaceuticals IPO.
| Akums Drugs IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,22,05,912 shares | 57,79,850 shares |
| Market Maker Reservation | ||
| QIB | 81,37,276 shares | 38,53,234 shares |
| NII | 40,68,637 shares | 28,89,926 shares |
| RII | 27,12,424 shares | 67,43,160 shares |
| Employee | 2,43,902 shares | 1,08,900 shares |
| Others | ||
| Total | 2,73,68,151 shares | 1,93,75,070 shares |
Akums Drugs IPO subscribed 63.44x in total, whereas Emcure Pharmaceuticals IPO subscribed 67.87x.
| Akums Drugs IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 90.09x | 191.24x |
| NII (times) | 42.10x | 49.32x |
| Big NII (times) | 47.43x | 54.90x |
| Small NII (times) | 31.45x | 38.16x |
| RII (times) | 20.80x | 7.36x |
| Employee (times) | 4.14x | 8.81x |
| Other (times) | ||
| Total (times) | 63.44x | 67.87x |
